deltatrials
Completed PHASE2 NCT00002642

SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer

Induction Chemoradiotherapy Followed by Surgical Resection for Non-small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumors): A Phase II Trial

Sponsor: Cancer and Leukemia Group B

Conditions Lung Cancer
Interventions cisplatin conventional surgery etoposide low-LET cobalt-60 gamma ray therapy
Updated 7 times since 2017 Last updated: Oct 5, 2012 Started: Apr 30, 1995 Primary completion: Jan 31, 2001 Completion: Jul 31, 2004

Listed as NCT00002642, this PHASE2 trial focuses on Lung Cancer and remains completed. Sponsored by Cancer and Leukemia Group B, it has been updated 7 times since 1995, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. May 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — May 2023 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Apr 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cancer and Leukemia Group B
  • Eastern Cooperative Oncology Group
  • NCIC Clinical Trials Group
  • National Cancer Institute (NCI)
  • North Central Cancer Treatment Group
  • SWOG Cancer Research Network
Data source: SWOG Cancer Research Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Nashville, United States